Colin Ross is much better now he’s completed his first course of the drug Revlimid. As Dr Kevin Boyd, his specialist at the Royal Marsden hospital predicted, the drug is having a dramatic effect on Ross’s cancer, multiple myeloma. His paraprotein levels – which indicate the rate of spread of the disease – have come down from 67 to five, which his partner, Wendy Forbes-Newbigin, calls “little short of a miracle”.
Additional Story
Finger on the Pulse: Max Pemberton on top-up payments and the NHS - The Telegraph 20th October 2008
0 comments:
Post a Comment